Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier
Замкнутая система «искусственная поджелудочная железа» с подкожным измерением уровня глюкозы и введением инсулина и алгоритмом управления на основе прогнозирующей модели: предварительные исследования в Падуе и Монпелье
2009-09-01
SCID: 54.1/ppykvvmq
Discuss with AI
artificial pancreascontinuous glucose monitoringcontinuous subcutaneous insulin infusionmodel predictive controltype 1 diabetes
Figures from the paper
Abstract (AI)
New effort has been made to develop closed-loop glucose control, using subcutaneous (SC) glucose sensing and continuous subcutaneous insulin infusion (CSII) from a pump, and a control algorithm. An approach based on a model predictive control (MPC) algorithm has been utilized during closed-loop control in type 1 diabetes patients. Here we describe the preliminary clinical experience with this approach. Six type 1 diabetes patients (three in each of two clinical investigation centers in Padova and Montpellier), using CSII, aged 36 +/- 8 and 48 +/- 6 years, duration of diabetes 12 +/- 8 and 29 +/- 4 years, hemoglobin A1c 7.4% +/- 0.1% and 7.3% +/- 0.3%, body mass index 23.2 +/- 0.3 and 28.4 +/- 2.2 kg/m(2), respectively, were studied on two occasions during 22 h overnight hospital admissions 2-4 weeks apart. A Freestyle Navigator(R) continuous glucose monitor and an OmniPod insulin pump were applied in each trial. Admission 1 used open-loop control, while admission 2 employed closed-loop control using our MPC algorithm. In Padova, two out of three subjects showed better performance with the closed-loop system compared to open loop. Altogether, mean overnight plasma glucose (PG) levels were 134 versus 111 mg/dl during open loop versus closed loop, respectively. The percentage of time spent at PG > 140 mg/dl was 45% versus 12%, while postbreakfast mean PG was 165 versus 156 mg/dl during open loop versus closed loop, respectively. Also, in Montpellier, two patients out of three showed a better glucose control during closed-loop trials. Avoidance of nocturnal hypoglycemic excursions was a clear benefit during algorithm-guided insulin delivery in all cases. This preliminary set of studies demonstrates that closed-loop control based entirely on SC glucose sensing and insulin delivery is feasible and can be applied to improve glucose control in patients with type 1 diabetes, although the algorithm needs to be further improved to achieve better glycemic control.
Key Findings
1
A model predictive control algorithm enabled closed-loop glucose regulation using only subcutaneous glucose sensing and continuous subcutaneous insulin infusion.
2
Closed-loop control reduced the proportion of time with plasma glucose above 140 mg/dl from 45% to 12% in Padova.
3
In Padova, two of three patients performed better with closed-loop control; mean overnight plasma glucose decreased from 134 to 111 mg/dl.
4
Nocturnal hypoglycemic excursions were avoided in all cases, while the algorithm requires further improvement for better glycemic control.
5
Postbreakfast mean plasma glucose improved from 165 to 156 mg/dl during closed-loop control in Padova.
Research Object
Closed-loop artificial pancreas using subcutaneous glucose sensing and continuous subcutaneous insulin infusion in patients with type 1 diabetes
Research Subject
Feasibility and glycemic-control performance of model-predictive-control-guided insulin delivery, including overnight glucose regulation and avoidance of nocturnal hypoglycemia
Publication Details
Publication Date
2009-09-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
156
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest